Birgit Helmlinger

Birgit Helmlinger

Auto-generated profile, based on publicly available information

Birgit Helmlinger

Department of Neurology, Medical University of Graz, Austria

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in European Journal of Neurology
Verified
Journal Article
Open access
ABArabella Buchmann
Arabella Buchmann
LPLukas Pirpamer
Lukas Pirpamer
DPDaniela Pinter
Daniela Pinter
MVMargarete Voortman
Margarete Voortman
BHBirgit Helmlinger
Birgit Helmlinger
MKMichael Khalil
Michael Khalil
Background and purpose: Serum neurofilament light chain (sNfL) is a promising biomarker of neuroaxonal damage in persons with multiple sclerosis (pwMS). In cross‐sectional studies, sNfL has been associated with disease activity and brain magnetic resonance imaging (MRI) changes; however, it is still unclear to what extent in particular high sNfL levels impact on subsequent disease evolution.Methods: sNfL was quantified by an ultrasensitive single molecule array (Simoa) in 199 pwMS (median age = 34.2 years, 64.3% female) and 49 controls. All pwMS underwent 3‐T MRI to assess global and compartmental normalized brain volumes, T2‐lesion load, and cortical mean thickness. Follow‐up data and serum samples were available in 144 pwMS (median follow‐up time = 3.8 years). Linear and binary logistic models were used to estimate the independent contribution of sNfL for changes in MRI and Expanded Disability Status Scale (EDSS). Age‐corrected sNfL z‐scores from a normative database of healthy controls were used for sensitivity analyses.Results: High sNfL levels at baseline were associated with atrophy measures of the whole brain (standardized beta coefficient βj = −0.352, p < 0.001), white matter (βj = −0.229, p = 0.007), thalamus (βj = −0.372, p = 0.004), and putamen (βj = −1.687, p = 0.012). pwMS with high levels of sNfL at baseline and follow‐up had a greater risk of EDSS worsening (p = 0.007).Conclusions: Already single time point elevation of sNfL has a distinct effect on brain volume changes over a short‐term period, and repeated high levels of sNfL indicate accumulating physical disability. Serial assessment of sNfL may provide added value in the clinical management of pwMS.

5 March 2024 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
SHStefanie Hechenberger
Stefanie Hechenberger
BHBirgit Helmlinger
Birgit Helmlinger
CTChristian Tinauer
Christian Tinauer
EJEmanuel Jauk
Emanuel Jauk
SRStefan Ropele
Stefan Ropele
DPDaniela Pinter
Daniela Pinter
Background: Limited resources often hinder regular cognitive assessment of people with multiple sclerosis (pwMS) in standard clinical care. A self-administered iPad®-based cognitive screening-tool (Processing Speed Test; PST) might mitigate this problem. Objective: To evaluate the PST in clinical routine. Methods: We investigated the feasibility of the PST in both a quiet and a waiting room setting. We assessed the validity of the PST in comparison with the established Symbol Digit Modalities Test (SDMT). We explored associations between processing speed assessments and the Brief International Cognitive Assessment for MS (BICAMS), magnetic resonance imaging (MRI) parameters, and psychological factors. Additionally, we explored the ability of the PST to detect impairment in processing speed compared to the SDMT. Results: The PST was feasible in the waiting room setting. PST and SDMT correlated comparably with the BICAMS, MRI parameters, and psychological variables. Of 172 pwMS, 50 (30.8%) showed cognitive impairment according to the BICAMS; respective values were 47 (27.3%) for the SDMT and 9 (5.2%) for the PST. Conclusions: The PST performed in a waiting room setting correlates strongly with established cognitive tests. It thus may be used to assess processing speed in a resource-efficient manner and complement cognitive assessment in clinical routine. Despite comparable validity of the PST and SDMT, we identified more pwMS with impaired processing speed using normative data of the SDMT compared to the PST and advise caution, that the common cut-off score of – 1.5 SD from the current PST is not appropriate in Europe.

26 March 2026 in Movement Disorders
Verified
Journal Article
Open access
MSMelanie Suette
Melanie Suette
RMRobert Matic
Robert Matic
MKMarisa Koini
Marisa Koini
LGLukas Gattermeyer
Lukas Gattermeyer
DKDaniela Kern
Daniela Kern
Petra SchwingenschuhPetra Schwingenschuh
Petra Schwingenschuh
Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder clinically defined by three cardinal motor symptoms: bradykinesia, rigidity, and tremor. Although the natural history of bradykinesia and rigidity is well described, the evolution of tremor as the disease progresses remains controversial. Objectives: The goal was to clinically characterize long‐term trajectories of rest, postural, and action tremor in PD and examine their neural network correlates using longitudinal resting‐state functional magnetic resonance imaging (rs‐fMRI). Methods: In this retrospective longitudinal cohort study, we analyzed 93 tremor‐positive PD patients (mean disease duration: 3.6 years), each with up to six clinical assessments over 4.2 years. Linear mixed‐effects models assessed temporal change in Movement Disorder Society‐Unified Parkinson's Disease Rating Scale (MDS‐UPDRS) and Fahn–Tolosa–Marín Tremor Rating Scale (FTM‐TRS) scores. Rs‐fMRI data from 30 tremor‐affected patients (mean interval, 3.35 years) were analyzed for seed‐to–whole‐brain connectivity and connectivity between predefined brain regions. Results: Bradykinesia (β = +0.09, P < 0.001) and rigidity (β = +0.06, P < 0.001) worsened, whereas total FTM‐TRS scores declined by 0.49 points/year ( P = 0.037), driven by reductions in postural ( P < 0.001) and action tremor ( P = 0.033); resting tremor remained stable. Rs‐fMRI revealed longitudinal changes in cerebellar‐ and thalamic‐seed‐to‐whole‐brain connectivity. Conclusions: Tremor in PD evolves along distinct clinical courses, often stabilizing or improving as other motor features worsen. These findings are consistent with partially adaptive reorganization within tremor‐related networks and underscore the importance of identifying patient subtypes with divergent trajectories to inform prognosis and optimize therapy. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

1 September 2026 in Neurology Open Access
Verified
Journal Article
Open access
PDF file
MMMaria Martinez-Serrat
Maria Martinez-Serrat
CTCansu Tafrali
Cansu Tafrali
RDRina Demjaha
Rina Demjaha
TKTimothy Kaiser
Timothy Kaiser
MHMichaela Tanja Haindl
Michaela Tanja Haindl
MKMichael Khalil
Michael Khalil
Background and ObjectivesMonitoring disease activity in patients with multiple sclerosis (MS) remains challenging, and studying blood-based biomarkers that improve prognostic accuracy in routine cl...

8 March 2026 in Human Brain Mapping
Verified
Journal Article
Open access
SHStefanie Hechenberger
Stefanie Hechenberger
TBTommy A. A. Broeders
Tommy A. A. Broeders
MBMarloes D. A. Bet
Marloes D. A. Bet
BHBirgit Helmlinger
Birgit Helmlinger
CTChristian Tinauer
Christian Tinauer
DPDaniela Pinter
Daniela Pinter
Fatigue affects between 36.5% and 78% of people with multiple sclerosis (pwMS) and significantly impairs daily life. The neurobiological mechanisms underlying fatigue remain poorly understood and information about the time‐varying communication between brain regions and the networks they form may offer new insights into the complex pathology of MS‐related fatigue. Brain regions continuously reconfigure how they communicate within distinct networks (i.e., time‐varying reconfigurations) and aberrant time‐varying reconfigurations may contribute to the perception of fatigue in pwMS. This study aimed to explore if and how time‐varying reconfigurations are associated with fatigue in pwMS. In this cross‐sectional study, 155 pwMS (62% female; age = 39 ± 10 years; disease duration = 10 ± 8 years; median EDSS = 1.0 ± 2.0) and 48 healthy controls (HC) (71% female; age = 33 ± 10 years) underwent clinical, neuropsychological, and (resting‐state functional) MRI assessments. Fatigue was evaluated with the “Fatigue Scale for Motor and Cognitive Function”, comprising total, motor, and cognitive fatigue scores. Time‐varying connectivity was derived using a sliding‐window approach, with data‐driven assignment of brain regions to one of eight resting‐state networks for each window. Promiscuity (dispersion of reconfigurations), flexibility (frequency of reconfigurations), cohesion (joint reconfigurations), and disjointedness (independent reconfigurations) described the time‐varying reconfigurations of the whole brain and its networks. Among pwMS, 57% reported experiencing at least mild total fatigue (motor: 60%, cognitive: 57%). Higher total fatigue was correlated with greater global promiscuity ( r = 0.21, p = 0.032) and disjointedness ( r = 0.24, p = 0.008). Similarly, higher motor fatigue was associated with greater global promiscuity ( r = 0.25, p = 0.008), flexibility ( r = 0.21, p = 0.032), and disjointedness ( r = 0.28, p < 0.001). The associations with disjointedness remained significant even after controlling for demographics, clinical measures, and structural brain damage, such as lesion load and atrophy (total fatigue: adj. R 2 = 0.23, β = 0.17, p = 0.033; motor fatigue: adj. R 2 = 0.38, β = 0.16, p = 0.026). Network‐level analyses in pwMS revealed that higher total ( r = 0.25, p = 0.016) and motor ( r = 0.25, p = 0.016) fatigue were associated with greater limbic network promiscuity. No significant correlations were found for cognitive fatigue in pwMS, or for total, motor, and cognitive fatigue in HC (all p > 0.05). Elevated levels of fatigue, particularly motor fatigue, in pwMS were linked to more unstable network reconfigurations, particularly of regions in the limbic network, possibly reflecting dysfunctional reward processing. More frequent dispersion requires more energy and may therefore contribute to increased fatigue. Trial Registration: This project was pre‐registered at ClinicalTrials.gov (registration number: NCT04892134)

16 February 2026 in medRxiv
Verified
Preprint
Open access
PDF file
MBMar Barrantes-Cepas
Mar Barrantes-Cepas
MTMario Tranfa
Mario Tranfa
DNDavid Rudolf van Nederpelt
David Rudolf van Nederpelt
IKIsmail Koubiyr
Ismail Koubiyr
LLLuigi Lorenzini
Luigi Lorenzini
GPGiuseppe Pontillo
Giuseppe Pontillo
Clinical progression is strongly linked to grey matter atrophy in multiple sclerosis (MS), detectable early on MRI and progressing non-randomly across the brain. However, the mechanisms driving its spatio-temporal progression and individual variability remain unclear. Using MRIs from 2,187 participants, alongside normative data, we systematically investigated network-based mechanisms underlying MS-related atrophy. Regional atrophy colocalised with functional cortical hubs, supporting the nodal stress hypothesis, and propagated along anatomical and functional connections, consistent with transneuronal degeneration. Lesional disconnection and transcriptomic vulnerability played marginal roles. Patient- and subgroup-level analyses revealed that network-based mechanisms are specifically linked to MS-related neurodegeneration and may operate differently in distinct subtypes or disease phases. Atrophy patterns were anchored to the connectivity profiles of disease epicentres involving the visual, sensorimotor, and temporal cortices, and the hippocampi and thalami. Network-based measures enhanced the prediction of future atrophy progression in individual with MS, providing a mechanistic framework to understand neurodegeneration in MS.